Favipiravir – Concept to commercialisation in less than 2 months, we have commercialized Favipiravir API suitable for global market

Favipiravir is the generic version of Avigan. The drug has demonstrated positive outcomes, including a reduction in the duration of Covid-19 and improved lung conditions for the patients.

Aurore Lifesciences is the first Indian API manufactured to have commercialized the Favipiravir API for global market.

We offer this API from our Unit 1 site with quality accreditations and compliances. We have the API ready with completed documentation as per ICH and supply chain control established.

148

Like this project

F.A.Q

Support Forum

Video Tutorials

Search panel can contain any widgets and shortcodes.

Call us: 0 800 255 22 55

Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.

Contacts & enquiries

Address: Aurore Life Sciences Pvt Ltd, Jubilee Heights, 2nd Floor, Beside Shilparamam, Hitech City,Hyderabad – 500 081, India

Email: info@aurorels.com

Phone: +91 40 23113211

Fax : +91-40-2311 0044

Favipiravir – Concept to commercialisation in less than 2 months, we have commercialized Favipiravir API suitable for global market

Contacts & enquiries

Write to us